{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:21:03Z","timestamp":1791973263728,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:00:00Z","timestamp":1610928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009793","name":"Stiftelsen B\u00f6rje Dahlins Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011898","name":"Marianne and Marcus Wallenberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011898","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009800","name":"Stiftelsen Professor Nanna Svartz Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009800","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007949","name":"Reumatikerf\u00f6rbundet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007857","name":"Stiftelsen Konung Gustaf V:s 80-\u00e5rsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.semarthrit.2020.12.009","type":"journal-article","created":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T18:21:27Z","timestamp":1608834087000},"page":"331-337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Overall and site-specific cancer before and after diagnosis of idiopathic inflammatory myopathies: A nationwide study 2002\u20132016"],"prefix":"10.1016","volume":"51","author":[{"given":"Lara","family":"Dani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weng","family":"Ian Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid E.","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Hellgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Holmqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.semarthrit.2020.12.009_bib0001","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM199202063260602","article-title":"Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study","volume":"326","author":"Sigurgeirsson","year":"1992","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.12.009_bib0002","first-page":"9","article-title":"Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark","volume":"6","author":"Chow","year":"1995","journal-title":"Cancer Causes Control"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.12.009_bib0003","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0049-0172(98)80052-8","article-title":"High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis","volume":"27","author":"Maoz","year":"1998","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.12.009_bib0004","first-page":"219","article-title":"Classical and amyopathic dermatomyositis seen at the National Skin Centre of Singapore: a 3-year retrospective review of their clinical characteristics and association with malignancy","volume":"29","author":"Ang","year":"2000","journal-title":"Ann Acad Med Singapore"},{"issue":"12","key":"10.1016\/j.semarthrit.2020.12.009_bib0005","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","article-title":"Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study","volume":"134","author":"Buchbinder","year":"2001","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.12.009_bib0006","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1054\/bjoc.2001.1699","article-title":"Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study","volume":"85","author":"Stockton","year":"2001","journal-title":"Br J Cancer"},{"issue":"9250","key":"10.1016\/j.semarthrit.2020.12.009_bib0007","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.semarthrit.2020.12.009_bib0008","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3899\/jrheum.090549","article-title":"Malignancy is associated with dermatomyositis but not polymyositis in Northern New England, USA","volume":"36","author":"Antiochos","year":"2009","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.12.009_bib0009","doi-asserted-by":"crossref","first-page":"843","DOI":"10.47102\/annals-acadmedsg.V39N11p843","article-title":"An 11-year review of dermatomyositis in Asian patients","volume":"39","author":"Liu","year":"2010","journal-title":"Ann Acad Med Singapore"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.12.009_bib0010","doi-asserted-by":"crossref","first-page":"R70","DOI":"10.1186\/ar2987","article-title":"Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan","volume":"12","author":"Chen","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.12.009_bib0011","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2133.2011.10595.x","article-title":"Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study","volume":"165","author":"Kuo","year":"2011","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.12.009_bib0012","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3109\/s10165-010-0362-y","article-title":"Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis","volume":"21","author":"Azuma","year":"2011","journal-title":"Mod Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.12.009_bib0013","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.3899\/jrheum.110320","article-title":"Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis","volume":"38","author":"So","year":"2011","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.12.009_bib0014","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00296-012-2489-y","article-title":"The incidence and associations of malignancy in a large cohort of patients with biopsy-determined idiopathic inflammatory myositis","volume":"33","author":"Limaye","year":"2013","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.12.009_bib0015","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3899\/jrheum.140566","article-title":"Polymyositis\/dermatomyositis and malignancy risk: a metaanalysis study","volume":"42","author":"Yang","year":"2015","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.12.009_bib0016","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/rheumatology\/kew215","article-title":"Temporal relationship between cancer and myositis identifies two distinctive subgroups of cancers: impact on cancer risk and survival in patients with myositis","volume":"55","author":"Kang","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.12.009_bib0017","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s10067-016-3296-8","article-title":"Malignancy in dermatomyositis and polymyositis: analysis of 192 patients","volume":"35","author":"Fang","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.12.009_bib0018","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12016-015-8511-x","article-title":"Idiopathic inflammatory myopathies and malignancy: a comprehensive review","volume":"52","author":"Tiniakou","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.12.009_bib0019","first-page":"1","article-title":"Sweden health system review","volume":"14","author":"Anell","year":"2012","journal-title":"Health Syst Transit"},{"key":"10.1016\/j.semarthrit.2020.12.009_bib0020","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.12.009_bib0021","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/02841860802247664","article-title":"The completeness of the Swedish Cancer Register \u2013 a sample survey for year 1998","volume":"48","author":"Barlow","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1016\/j.semarthrit.2020.12.009_bib0022","unstructured":"Cancer Incidence in Sweden 2005. Centre for epidemiology. National Board of Health and Welfare. Official Statistics of Sweden. Health Diseases 2007:3. Published at: http:\/\/www.socialstyrelsen.se\/Publicerat\/2007\/9514\/2007-42-3.htm (assessed 19 Jun, 2019)."},{"issue":"2","key":"10.1016\/j.semarthrit.2020.12.009_bib0023","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","article-title":"Registers of the Swedish total population and their use in medical research","volume":"31","author":"Ludvigsson","year":"2016","journal-title":"Eur J Epidemiol"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.12.009_bib0024","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10654-009-9350-y","article-title":"The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research","volume":"24","author":"Ludvigsson","year":"2009","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.semarthrit.2020.12.009_bib0025","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2147\/CLEP.S90589","article-title":"Ethical aspects of registry-based research in the Nordic countries","volume":"7","author":"Ludvigsson","year":"2015","journal-title":"Clin Epidemiol"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.12.009_bib0026","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/rheumatology\/kew503","article-title":"Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study","volume":"56","author":"Svensson","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2020.12.009_bib0027","series-title":"Statistical code for human tumours (WHO\/HS\/CANC.\/24.1)","author":"Organization","year":"1956"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.12.009_bib0028","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.juro.2012.12.014","article-title":"Autoimmune disease and subsequent urological cancer","volume":"189","author":"Liu","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.semarthrit.2020.12.009_bib0029","first-page":"12","article-title":"Centre for Epidemiology. National Board of Health and Welfare. Official Statistics of Sweden","volume":"2018","year":"2017","journal-title":"Health and Diseases"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.12.009_bib0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s13075-017-1469-8","article-title":"Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study","volume":"19","author":"Yang","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.12.009_bib0031","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/01.bor.0000245721.02512.77","article-title":"Cancer and myositis: new insights into an old association","volume":"18","author":"Levine","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.12.009_bib0032","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3389\/fimmu.2017.00992","article-title":"Dermatomyositis and immune-mediated necrotizing myopathies: a window on autoimmunity and cancer","volume":"8","author":"Aussy","year":"2017","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.12.009_bib0033","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1084\/jem.20041367","article-title":"Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy","volume":"201","author":"Casciola-Rosen","year":"2005","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.12.009_bib0034","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2340\/00015555-1550","article-title":"TIF1gamma-overexpressing, highly progressive endometrial carcinoma in a patient with dermato-myositis positive for malignancy-associated anti-p155\/140 autoantibody","volume":"93","author":"Kasuya","year":"2013","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.12.009_bib0035","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/ajg.2009.745","article-title":"Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case-control study","volume":"105","author":"Armstrong","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.12.009_bib0036","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/aje\/kws375","article-title":"Use of azathioprine and the risk of cancer in inflammatory bowel disease","volume":"177","author":"Pasternak","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.12.009_bib0037","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1523-1747.2003.12040.x","article-title":"Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study","volume":"120","author":"Paul","year":"2003","journal-title":"J Invest Dermatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.12.009_bib0038","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/rheumatology\/kew214","article-title":"Disease-modifying anti-rheumatic drugs and non-melanoma skin cancer in inflammatory arthritis patients: a retrospective cohort study","volume":"55","author":"Lange","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.12.009_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9343(87)90490-6","article-title":"Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. Long-term case-control follow-up study","volume":"83","author":"Baker","year":"1987","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.12.009_bib0040","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/ard.2008.096925","article-title":"Rheumatoid arthritis, treatment with corticosteroids and risk of malignant lymphomas: results from a case-control study","volume":"69","author":"Hellgren","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.12.009_bib0041","doi-asserted-by":"crossref","first-page":"e94128","DOI":"10.1371\/journal.pone.0094128","article-title":"Factors predicting malignancy in patients with polymyositis and dermatomyostis: a systematic review and meta-analysis","volume":"9","author":"Lu","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.semarthrit.2020.12.009_bib0042","article-title":"Retrospective analysis of cancer-associated myositis patients over the Past 3 decades in a Hungarian Myositis Cohort","author":"Andras","year":"2019","journal-title":"Pathol Oncol Res"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.12.009_bib0043","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/rheumatology\/key357","article-title":"The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody\u2013positive dermatomyositis","volume":"58","author":"Oldroyd","year":"2019","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.12.009_bib0044","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11926-002-0087-9","article-title":"Malignancy in patients with inflammatory myopathy","volume":"4","author":"Buchbinder","year":"2002","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.12.009_bib0045","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrrheum.2018.48","article-title":"Risk factors and disease mechanisms in myositis","volume":"14","author":"Miller","year":"2018","journal-title":"Nat Rev Rheumatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220303176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220303176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:07:42Z","timestamp":1758733662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017220303176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0049017220303176"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.12.009","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overall and site-specific cancer before and after diagnosis of idiopathic inflammatory myopathies: A nationwide study 2002\u20132016","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}